Laryngeal edema following remimazolam-induced anaphylaxis: a rare clinical manifestation
Abstract Background Remimazolam is an ultra-short-acting intravenous benzodiazepine, which has been used as sedative/anesthetic in procedural sedation and anesthesia. Although peri-operative anaphylaxis due to remimazolam has been reported recently, the spectrum of the allergic reactions is still no...
Main Authors: | Xiawei Hu, Yaning Tang, Xiangming Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Anesthesiology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12871-023-02052-w |
Similar Items
-
Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program
by: Tatsuya Hirano, et al.
Published: (2023-09-01) -
Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures
by: Morimoto Y
Published: (2022-02-01) -
Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress
by: Wang M, et al.
Published: (2022-10-01) -
Safety and effcacy of remimazolam tosilate for sedation during combined spinal-epidural anesthesia for orthopedic procedures: a randomized controlled trial
by: Yufei Chen, et al.
Published: (2024-02-01) -
Remimazolam Pilot for Office-Based Dental Sedation: Adverse Events, Awareness and Outcomes
by: Rudi Swart, et al.
Published: (2023-11-01)